Lotus Bio-Technology Development

Lotus Bio-Technology Development Documenten

Documenten

95

Ticker

LBTD

ISIN

US54570R1077

Omzet Winst K/W-verhouding P/S EBIT Dividend Insiertransacties Aandelen Marktkapitalisatie Schuld Verplichtingen Eigen vermogen AAQS Medewerkers ROE ROA ROCE News Documenten

Lotus Bio-Technology Development SEC Filings

Type
Bericht
Datum
DD-Formular23-12-2022
15-12G15-12G-Formular9-6-2021
10-Q/A10-Q/A-Formular7-4-2021
10-Q/A10-Q/A-Formular23-2-2021
10-Q/A10-Q/A-Formular27-1-2021
10-K/A10-K/A-Formular21-1-2021
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben20-9-2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10-4-2019
NT 10-KNT 10-K-Formular29-6-2018
10-QQuartalsbericht13-2-2018
10-QQuartalsbericht13-11-2017
10-Q/A10-Q/A-Formular13-9-2017
10-QQuartalsbericht21-8-2017
NT 10-QNT 10-Q-Formular14-8-2017
10-KJahresbericht14-7-2017
NT 10-KNT 10-K-Formular29-6-2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben19-6-2017
10-QQuartalsbericht8-5-2017
NT 10-QNT 10-Q-Formular14-2-2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10-2-2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben29-11-2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben28-11-2016
10-QQuartalsbericht21-11-2016
NT 10-QNT 10-Q-Formular14-11-2016
10-QQuartalsbericht27-9-2016
10-KJahresbericht27-9-2016
NT 10-K/ANT 10-K/A-Formular30-6-2016
NT 10-KNT 10-K-Formular29-6-2016
S-8 POSS-8 POS-Formular11-4-2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8-4-2016
S-8 POSS-8 POS-Formular5-4-2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1-4-2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1-4-2016
10-QQuartalsbericht16-2-2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben19-1-2016
S-8 POSS-8 POS-Formular17-11-2015
10-QQuartalsbericht16-11-2015
S-8 POSS-8 POS-Formular9-10-2015
10-Q/A10-Q/A-Formular10-9-2015
S-8 POSS-8 POS-Formular31-8-2015
S-8S-8-Formular25-8-2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben17-8-2015
10-QQuartalsbericht12-8-2015
10-KJahresbericht29-7-2015
10-Q/A10-Q/A-Formular17-7-2015
NT 10-KNT 10-K-Formular30-6-2015
10-QQuartalsbericht23-2-2015
10-QQuartalsbericht18-11-2014
NT 10-QNT 10-Q-Formular14-11-2014
10-QQuartalsbericht19-8-2014
NT 10-QNT 10-Q-Formular14-8-2014
10-KJahresbericht15-7-2014
NT 10-KNT 10-K-Formular30-6-2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12-5-2014
10-K/A10-K/A-Formular25-4-2014
10-QQuartalsbericht24-2-2014
NT 10-QNT 10-Q-Formular18-2-2014
10-QQuartalsbericht14-11-2013
10-QQuartalsbericht14-8-2013
10-KJahresbericht1-7-2013
10-Q/A10-Q/A-Formular25-2-2013
10-Q/A10-Q/A-Formular25-2-2013
10-K/A10-K/A-Formular25-2-2013
10-QQuartalsbericht19-2-2013
NT 10-QNT 10-Q-Formular15-2-2013
10-QQuartalsbericht13-11-2012
10-QQuartalsbericht2-8-2012
33-Formular2-7-2012
8-A12G8-A12G-Formular25-6-2012
10-KJahresbericht22-6-2012
424B3424B3-Formular3-4-2012
EFFECTEFFECT-Formular29-3-2012
CORRESPCORRESP-Formular26-3-2012
S-1/AS-1/A-Formular20-3-2012
S-1/AS-1/A-Formular13-3-2012
UPLOADUPLOAD-Formular12-3-2012
S-1/AS-1/A-Formular5-3-2012
UPLOADUPLOAD-Formular2-3-2012
S-1/AS-1/A-Formular21-2-2012
UPLOADUPLOAD-Formular14-2-2012
S-1/AS-1/A-Formular31-1-2012
UPLOADUPLOAD-Formular30-1-2012
S-1/AS-1/A-Formular13-1-2012
UPLOADUPLOAD-Formular12-1-2012
S-1/AS-1/A-Formular28-12-2011
UPLOADUPLOAD-Formular23-12-2011
S-1/AS-1/A-Formular16-12-2011
UPLOADUPLOAD-Formular18-11-2011
S-1/AS-1/A-Formular4-11-2011
UPLOADUPLOAD-Formular17-10-2011
S-1/AS-1/A-Formular3-10-2011
UPLOADUPLOAD-Formular19-8-2011
S-1/AS-1/A-Formular9-8-2011
UPLOADUPLOAD-Formular6-7-2011
S-1S-1-Formular10-6-2011

Lotus Bio-Technology Development Documenten 2026

Deze pagina bevat alle officiële documenten en SEC-filings voor Lotus Bio-Technology Development aandelen (LBTD, ISIN: US54570R1077). Dit omvat jaarverslagen (Formulier 10-K), kwartaalrapporten (Formulier 10-Q) en insidertransacties (Formulier 4). Momenteel zijn 95 documenten beschikbaar. Gegevens worden regelmatig bijgewerkt om beleggers een volledig overzicht van Lotus Bio-Technology Development's regelgevingsfilings te bieden.